145 related articles for article (PubMed ID: 28236038)
21. Evaluation of the Effect of Surgeon's Operative Volume and Specialty on Likelihood of Revision After Mesh Midurethral Sling Placement.
Brennand EA; Quan H
Obstet Gynecol; 2019 Jun; 133(6):1099-1108. PubMed ID: 31135723
[TBL] [Abstract][Full Text] [Related]
22. Predictors of postoperative complications from stress urinary incontinence procedures: a NSQIP database study.
Bonus ML; Luchristt D; Brown O; Collins S; Kenton K; Bretschneider CE
Int Urogynecol J; 2022 Aug; 33(8):2291-2297. PubMed ID: 35028702
[TBL] [Abstract][Full Text] [Related]
23. Postoperative erosions of the Mersilene suburethral sling mesh for antiincontinence surgery.
Wohlrab KJ; Erekson EA; Myers DL
Int Urogynecol J Pelvic Floor Dysfunct; 2009 Apr; 20(4):417-20. PubMed ID: 19082911
[TBL] [Abstract][Full Text] [Related]
24. National Surgical Trends and Perioperative Outcomes of Midurethral Sling Placement for Stress Urinary Incontinence.
Slopnick EA; Hijaz AK; Nguyen CT; Abouassaly R; Gonzalez CM; Mahajan ST; Henderson JW; Bream MJ; Kim SP
Urology; 2017 Jan; 99():57-61. PubMed ID: 27669653
[TBL] [Abstract][Full Text] [Related]
25. Commentary on: Suburethral sling procedures in the United States: complications, readmission, and reoperation.
Grisales T
Int Urogynecol J; 2018 Feb; 29(2):321. PubMed ID: 29046920
[No Abstract] [Full Text] [Related]
26. Post-hospital syndrome predicts poor postoperative outcomes and increased cost following transvaginal midurethral sling placement.
Hart ST; Nelson M; Kirshenbaum E; Chen Y; Mueller ER; Gupta G
Int Urogynecol J; 2020 Jul; 31(7):1417-1422. PubMed ID: 31197429
[TBL] [Abstract][Full Text] [Related]
27. A Comparison of Perioperative Outcomes, Readmission, and Reoperation for Sacrospinous Ligament Fixation, Uterosacral Ligament Suspension, and Minimally Invasive Sacrocolpopexy.
Yadav GS; Gaddam N; Rahn DD
Female Pelvic Med Reconstr Surg; 2021 Mar; 27(3):133-139. PubMed ID: 33620894
[TBL] [Abstract][Full Text] [Related]
28. Repeat surgery after failed midurethral slings: a nationwide cohort study, 1998-2007.
Hansen MF; Lose G; Kesmodel US; Gradel KO
Int Urogynecol J; 2016 Jul; 27(7):1013-9. PubMed ID: 26713329
[TBL] [Abstract][Full Text] [Related]
29. A randomised comparison of single-incision versus traditional transobturator midurethral sling in women with stress urinary incontinence: results of a 24-month follow-up.
Schellart RP; Oude Rengerink K; Van der Aa F; Lucot JP; Kimpe B; Dijkgraaf MG; Roovers JP
Int Urogynecol J; 2016 Jun; 27(6):871-7. PubMed ID: 26670576
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for failure of repeat midurethral sling surgery for recurrent or persistent stress urinary incontinence.
Lo TS; Pue LB; Tan YL; Wu PY
Int Urogynecol J; 2016 Jun; 27(6):923-31. PubMed ID: 26700103
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for 30-day reoperation and 3-month readmission: analysis from the Quality and Outcomes Database lumbar spine registry.
Wadhwa RK; Ohya J; Vogel TD; Carreon LY; Asher AL; Knightly JJ; Shaffrey CI; Glassman SD; Mummaneni PV
J Neurosurg Spine; 2017 Aug; 27(2):131-136. PubMed ID: 28574331
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for mesh erosion after vaginal sling procedures for urinary incontinence.
Kokanali MK; Doğanay M; Aksakal O; Cavkaytar S; Topçu HO; Özer İ
Eur J Obstet Gynecol Reprod Biol; 2014 Jun; 177():146-50. PubMed ID: 24793930
[TBL] [Abstract][Full Text] [Related]
33. Postoperative groin pain and success rates following transobturator midurethral sling placement: TVT ABBREVO® system versus TVT™ obturator system.
Canel V; Thubert T; Wigniolle I; Fernandez H; Deffieux X
Int Urogynecol J; 2015 Oct; 26(10):1509-16. PubMed ID: 25963058
[TBL] [Abstract][Full Text] [Related]
34. Contasure-needleless® compared with Monarc® for the treatment of stress urinary incontinence.
Fernandez-Gonzalez S; Martinez Franco E; Lin Miao X; Amat Tardiu L
Int Urogynecol J; 2017 Jul; 28(7):1077-1084. PubMed ID: 28025686
[TBL] [Abstract][Full Text] [Related]
35. Treatment of female stress urinary incontinence using suburethral slings: comparative, retrospective, observational study of two surgical techniques.
Castroviejo-Royo F; Martinez-Sagarra-Oceja JM; Marina-García-Tuñón C; Conde-Redondo C; Rodríguez-Toves LA; González-Tejero C
Actas Urol Esp; 2013 Oct; 37(9):549-53. PubMed ID: 23618512
[TBL] [Abstract][Full Text] [Related]
36. Assessment of Adverse Events in a Matched Cohort of Women Undergoing Concurrent Midurethral Sling at the Time of Minimally Invasive Benign Gynecologic Surgery.
Wood N; Casas-Puig V; Ferrando CK
Urogynecology (Phila); 2022 Dec; 28(12):862-871. PubMed ID: 36409644
[TBL] [Abstract][Full Text] [Related]
37. Utility of Preoperative Laboratory Testing in Women Undergoing Suburethral Sling.
Pandya LK; McLaughlin EM; Hudson CO; Nekkanti S; Smith PE; Hade EM; Hundley AF
Female Pelvic Med Reconstr Surg; 2019; 25(2):99-104. PubMed ID: 30807408
[TBL] [Abstract][Full Text] [Related]
38. Unplanned Hospital Visits in the First 30 Days After Urethral Sling Procedures.
Dallas KB; Rogo-Gupta L; Elliott CS
Urology; 2017 May; 103():79-83. PubMed ID: 28153590
[TBL] [Abstract][Full Text] [Related]
39. Predictors of vaginal mesh exposure after midurethral sling placement: a case-control study.
Linder BJ; El-Nashar SA; Carranza Leon DA; Trabuco EC
Int Urogynecol J; 2016 Sep; 27(9):1321-6. PubMed ID: 26811112
[TBL] [Abstract][Full Text] [Related]
40. Population based trends in procedures following sling surgery for urinary incontinence.
Suskind AM; Kaufman SR; Dunn RL; Stoffel JT; Clemens JQ; Hollenbeck BK
Int Urogynecol J; 2013 May; 24(5):775-80. PubMed ID: 22930217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
